These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32758586)

  • 1. Minutes of PPAR-γ agonism and neuroprotection.
    Prashantha Kumar BR; Kumar AP; Jose JA; Prabitha P; Yuvaraj S; Chipurupalli S; Jeyarani V; Manisha C; Banerjee S; Jeyabalan JB; Mohankumar SK; Dhanabal SP; Justin A
    Neurochem Int; 2020 Nov; 140():104814. PubMed ID: 32758586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders.
    Justin A; Mandal S; Prabitha P; Dhivya S; Yuvaraj S; Kabadi P; Sekhar SJ; Sandhya CH; Wadhwani AD; Divakar S; Bharathi JJ; Durai P; Prashantha Kumar BR
    Neurotox Res; 2020 Mar; 37(3):508-524. PubMed ID: 31782098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.
    Lv J; Jiang S; Yang Z; Hu W; Wang Z; Li T; Yang Y
    Ageing Res Rev; 2018 Jul; 44():8-21. PubMed ID: 29580918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?
    Zolezzi JM; Silva-Alvarez C; Ordenes D; Godoy JA; Carvajal FJ; Santos MJ; Inestrosa NC
    PLoS One; 2013; 8(5):e64019. PubMed ID: 23675519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
    Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB
    Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glitazones, PPAR-γ and Neuroprotection.
    Kumar AP; P P; Kumar BRP; Jeyarani V; Dhanabal SP; Justin A
    Mini Rev Med Chem; 2021; 21(12):1457-1464. PubMed ID: 33663364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome Proliferator-Activated Receptor γ Coactivator 1α Activates Vascular Endothelial Growth Factor That Protects Against Neuronal Cell Death Following Status Epilepticus through PI3K/AKT and MEK/ERK Signaling.
    Huang JB; Hsu SP; Pan HY; Chen SD; Chen SF; Lin TK; Liu XP; Li JH; Chen NC; Liou CW; Hsu CY; Chuang HY; Chuang YC
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
    Nierenberg AA; Ghaznavi SA; Sande Mathias I; Ellard KK; Janos JA; Sylvia LG
    Biol Psychiatry; 2018 May; 83(9):761-769. PubMed ID: 29502862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.
    Yang YN; Zhang MQ; Yu FL; Han B; Bao MY; Yan-He ; Li X; Zhang Y
    Biochem Pharmacol; 2023 Sep; 215():115717. PubMed ID: 37516277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell line.
    Giampietro L; Gallorini M; De Filippis B; Amoroso R; Cataldi A; di Giacomo V
    Neurochem Int; 2019 Jun; 126():239-245. PubMed ID: 30946848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.
    Katsouri L; Blondrath K; Sastre M
    IUBMB Life; 2012 Dec; 64(12):958-64. PubMed ID: 23129362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
    De Nuccio C; Bernardo A; Cruciani C; De Simone R; Visentin S; Minghetti L
    Exp Neurol; 2015 Sep; 271():506-14. PubMed ID: 26210873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.
    Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M
    J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics.
    P P; Justin A; Ananda Kumar TD; Chinaswamy M; Kumar BRP
    ACS Chem Neurosci; 2021 Jul; 12(13):2261-2272. PubMed ID: 34125534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease.
    Das NR; Vaidya B; Khare P; Bishnoi M; Sharma SS
    Curr Neurovasc Res; 2021; 18(5):497-507. PubMed ID: 34923943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.
    Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
    Li J; Dai A; Hu R; Zhu L; Tan S
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):603-14. PubMed ID: 20732852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.